GL1X · GenesisL1 explorer

MolNFT v1 · #127855 · protein

Crystal structure of human il-17AF

5N92 · Interleukin-17A: “Crystal structure of human il-17AF”. X-ray diffraction, 2 ligands (NAG, FUC), 3 pockets (best druggability 0.75). MolNFT v1 #127855 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5N92
Type
protein
Length
229 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Interleukin-17A; Interleukin-17F
UniProt
Q16552, Q96PD4
Ligands
NAG, FUC
Pockets
3 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 3% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInterleukin-17Aprotein1094% helix, 53% strandQ16552
FInterleukin-17Fprotein1203% helix, 50% strandQ96PD4

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains F
  • FUC · alpha-L-fucopyranose · sugar · chains F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11360.750.9438empty
22010.500.7626empty
31040.420.7716empty

Interfaces

1 interface between chains.

  • A–F · 2844 Ų buried · 49 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 5N92 · Crystal Structure of Human IL-17AF · the same entry in another collection · chain A against A, TM-score 1.00
  • Q16552 · AlphaFold monomer V2.0 prediction for interleukin-17A (Q16552) · a predicted model of the same protein · chain A against A, TM-score 0.81
  • Q96PD4 · AlphaFold monomer V2.0 prediction for interleukin-17F (Q96PD4) · a predicted model of the same protein · chain F against A, TM-score 0.77

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.